122 related articles for article (PubMed ID: 10747828)
1. A comparison of the photosensitizing potential of trovafloxacin with that of other quinolones in healthy subjects.
Ferguson J; McEwen J; Al-Ajmi H; Purkins L; Colman PJ; Willavize SA
J Antimicrob Chemother; 2000 Apr; 45(4):503-9. PubMed ID: 10747828
[TBL] [Abstract][Full Text] [Related]
2. Phototoxicity in quinolones: comparison of ciprofloxacin and grepafloxacin.
Ferguson J; Dawe R
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():93-8. PubMed ID: 9484878
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the bactericidal activity of trovafloxacin and ciprofloxacin, alone and in combination with cefepime, against Pseudomonas aeruginosa.
McNabb J; Quintiliani R; Nightingale CH; Nicolau DP
Chemotherapy; 2000; 46(6):383-9. PubMed ID: 11053903
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolone phototoxicity: a comparison of moxifloxacin and lomefloxacin in normal volunteers.
Man I; Murphy J; Ferguson J
J Antimicrob Chemother; 1999 May; 43 Suppl B():77-82. PubMed ID: 10382879
[TBL] [Abstract][Full Text] [Related]
5. Photoreactions with a fluoroquinolone antimicrobial: evening versus morning dosing.
Lowe NJ; Fakouhi TD; Stern RS; Bourget T; Roniker B; Swabb EA
Clin Pharmacol Ther; 1994 Nov; 56(5):587-91. PubMed ID: 7955823
[TBL] [Abstract][Full Text] [Related]
6. Eltrombopag (75 mg) does not induce photosensitivity: results of a clinical pharmacology trial.
Bowen CJ; Lobb KM; Park JW; Sanderson B; Ferguson J
Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):243-9. PubMed ID: 20831698
[TBL] [Abstract][Full Text] [Related]
7. Photosensitivity to lomefloxacin. A clinical and photobiological study.
Oliveira HS; Gonçalo M; Figueiredo AC
Photodermatol Photoimmunol Photomed; 2000 Jun; 16(3):116-20. PubMed ID: 10885440
[TBL] [Abstract][Full Text] [Related]
8. A study of the phototoxic potential of trovafloxacin in BALB/c mice.
Mayne JT; Johnson NJ; Kluwe WM; Lencoski DL; Polzer RJ
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():67-73. PubMed ID: 9222073
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of phototoxic potential of gemifloxacin in healthy volunteers compared with ciprofloxacin.
Vousden M; Ferguson J; Richards J; Bird N; Allen A
Chemotherapy; 1999; 45(6):512-20. PubMed ID: 10567783
[TBL] [Abstract][Full Text] [Related]
10. Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics.
Stuht H; Lode H; Koeppe P; Rost KL; Schaberg T
Antimicrob Agents Chemother; 1995 May; 39(5):1045-9. PubMed ID: 7625786
[TBL] [Abstract][Full Text] [Related]
11. Scarified photopatch testing in lomefloxacin photosensitivity.
Kurumaji Y; Shono M
Contact Dermatitis; 1992 Jan; 26(1):5-10. PubMed ID: 1318180
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.
Teng R; Harris SC; Nix DE; Schentag JJ; Foulds G; Liston TE
J Antimicrob Chemother; 1995 Aug; 36(2):385-94. PubMed ID: 8522468
[TBL] [Abstract][Full Text] [Related]
13. Photosensitivity induced by lomefloxacin with cross-photosensitivity to ciprofloxacin and fleroxacin.
Kimura M; Kawada A
Contact Dermatitis; 1998 Mar; 38(3):180. PubMed ID: 9536423
[No Abstract] [Full Text] [Related]
14. In vitro phototoxic activities of new quinolone antibacterial agents: lipid peroxidative potentials.
Fujita H; Matsuo I
Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):202-5. PubMed ID: 7880759
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections.
Cox CE
Am J Med; 1992 Apr; 92(4A):82S-86S. PubMed ID: 1316077
[TBL] [Abstract][Full Text] [Related]
16. Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers.
Teng R; Liston TE; Harris SC
J Antimicrob Chemother; 1996 May; 37(5):955-63. PubMed ID: 8737145
[TBL] [Abstract][Full Text] [Related]
17. Lack of phototoxicity potential with delafloxacin in healthy male and female subjects: comparison to lomefloxacin.
Dawe RS; Ferguson J; Ibbotson S; Lawrence L; Paulson S; Duffy E; Cammarata S
Photochem Photobiol Sci; 2018 Jun; 17(6):773-780. PubMed ID: 29721574
[TBL] [Abstract][Full Text] [Related]
18. Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology.
Visalli MA; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1996 Jan; 37(1):77-84. PubMed ID: 8647777
[TBL] [Abstract][Full Text] [Related]
19. Lomefloxacin photosensitivity.
Poh-Fitzpatrick MB
Arch Dermatol; 1994 Feb; 130(2):261. PubMed ID: 8304775
[No Abstract] [Full Text] [Related]
20. Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacin on staphylococci using an in-vitro dynamic model.
Firsov AA; Vasilov RG; Vostrov SN; Kononenko OV; Lubenko IY; Zinner SH
J Antimicrob Chemother; 1999 Apr; 43(4):483-90. PubMed ID: 10350376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
